NAMI SURGICAL LIMITED

Active United Kingdom

Research and experimental development on biotechnology

14 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
N

NAMI SURGICAL LIMITED

Research and experimental development on biotechnology

Founded 2 Dec 2021 Active United Kingdom 14 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 31 Mar 2026 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 17 Sept 2025 Next due 30 Sept 2026 4 months remaining
Net assets £2M £581K 2025 year on year
Total assets £2M £680K 2025 year on year
Total Liabilities £222K £98K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Website

www.example.com

Full company profile for NAMI SURGICAL LIMITED (SC716603), an active life sciences and medical technology company based in United Kingdom. Incorporated 2 Dec 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2022–2025)

Cash in Bank

£1.81M

Increased by £461.78k (+34%)

Net Assets

£2.20M

Increased by £581.42k (+36%)

Total Liabilities

£222.02k

Increased by £98.20k (+79%)

Turnover

N/A

Employees

14

Increased by 4 (+40%)

Debt Ratio

9%

Increased by 2 (+29%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 1May 2024Seed
Investor 2May 2024Seed
Investor 3May 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 55,416 Shares £1.90m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 Dec 202555,385£1.90m£34.39
22 Feb 202331£0.31£0.01

Officers

Officers

2 active 1 resigned
Status
Nikki Pamela PalfreyDirectorBritishUnited Kingdom516 Jun 2023Active
Rebecca ClearyDirectorScottishUnited Kingdom3522 Apr 2024Active

Shareholders

Shareholders (23)

Nicola Giuseppe Fenu
23.8%
45,000
G U Holdings Limited
15.9%
30,000

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

G U Holdings Limited

Ceased 22 Apr 2024

Ceased

Nicola Giuseppe Fenu

Ceased 22 Apr 2024

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
31 Mar 2026AccountsAnnual accounts made up to 31 Dec 2025
9 Jan 2026ResolutionResolutions
6 Jan 2026OfficersTermination of Damian James Mole as director on 24 Dec 2025
6 Jan 2026OfficersAppointment of Mr David O'reilly as director on 24 Dec 2025
30 Dec 2025CapitalAllotment of shares (GBP 24.4364) on 24 Dec 2025
31 Mar 2026 Accounts

Annual accounts made up to 31 Dec 2025

9 Jan 2026 Resolution

Resolutions

6 Jan 2026 Officers

Termination of Damian James Mole as director on 24 Dec 2025

6 Jan 2026 Officers

Appointment of Mr David O'reilly as director on 24 Dec 2025

30 Dec 2025 Capital

Allotment of shares (GBP 24.4364) on 24 Dec 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

1 months ago on 31 Mar 2026

Resolutions

3 months ago on 9 Jan 2026

Termination of Damian James Mole as director on 24 Dec 2025

4 months ago on 6 Jan 2026

Appointment of Mr David O'reilly as director on 24 Dec 2025

4 months ago on 6 Jan 2026

Allotment of shares (GBP 24.4364) on 24 Dec 2025

4 months ago on 30 Dec 2025